Dr. Van Bibber has over 25 years of CRO and medtech experience working in pre-clinical, clinical, incubator, start-up and commercial environments, including multiple small private equity backed companies. His successful record includes pre-clinical and clinical evaluations, regulatory submissions and approvals, commercialization, professional training and education, raising capital, staffing and resourcing, intellectual property filings and technology assessment. He has built pre-clinical programs, played critical roles in multiple clinical trials, authored original publications in peer reviewed journals and led efforts to advance life saving technologies in the cardiovascular and surgical spaces. Dr. Van Bibber received his Ph.D. in Physiology and Biophysics from the University of Washington.His contributions to technology assessment and clinical development have led to successful product introductions and corporate transactions in the fields of structural heart disease, heart failure, peripheral vascular disease and aortic disease.